TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells
PLOS Genetics · 2024
DOI: 10.1371/journal.pgen.1011159 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2024. Verfasst von Thomas G Scott und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia, United States of America. Hauptthemen laut MEDLINE: Breast Neoplasms, Chromatin, Fingers, Hair Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Common genetic variants in the repressive GATA-family transcription factor (TF) TRPS1 locus are associated with breast cancer risk, and luminal breast cancer cell lines are particularly sensitive to TRPS1 knockout. We introduced an inducible degron tag into the native TRPS1 locus within a luminal breast cancer cell line to identify the direct targets of TRPS1 and determine how TRPS1 mechanistically regulates gene expression. We acutely deplete over 80 percent of TRPS1 from chromatin within 30 minutes of inducing degradation. We find that TRPS1 regulates transcription of hundreds of genes, including those related to estrogen signaling. TRPS1 directly regulates chromatin structure, which causes estrogen receptor alpha (ER) to redistribute in the genome. ER redistribution leads to both repression and activation of dozens of ER target genes. Downstream from these primary effects, TRPS1 depletion represses cell cycle-related gene sets and reduces cell doubling rate. Finally, we show that high TRPS1 activity, calculated using a gene expression signature defined by primary TRPS1-regulated genes, is associated with worse breast cancer patient prognosis. Taken together, these data suggest a model in which TRPS1 modulates the genomic distribution of ER, both activating and repressing transcription of genes related to cancer cell fitness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia, United States of America.
- Center for Cell Analysis and Modeling, University of Connecticut, Farmington, Connecticut, United States of America.
- Department of Genetics and Genome Sciences, University of Connecticut, Farmington, Connecticut, United States of America.
- Department of Microbiology, Immunology, and Cancer, University of Virginia, Charlottesville, Virginia, United States of America.
- Cancer Center Member, University of Virginia, Charlottesville, Virginia, United States of America.
ORCID-Profile: Michael J Guertin
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Scott, T. G., Sathyan, K. M., Gioeli, D., & Guertin, M. J. (2024). TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011159
Vancouver
Scott TG, Sathyan KM, Gioeli D, Guertin MJ. TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells. PLOS Genetics. 2024. doi:10.1371/journal.pgen.1011159
BibTeX
@article{Scott2024,
author = {Scott, Thomas G and Sathyan, Kizhakke Mattada and Gioeli, Daniel and Guertin, Michael J},
title = {TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells},
journal = {PLOS Genetics},
year = {2024},
doi = {10.1371/journal.pgen.1011159}
}
EUVIMED